Abstract
Introduction
Inflammatory myofibroblastic tumor (IMT) is a rare and distinctive neoplasm with an intermediate biologic potential. These tumors show a predilection for the abdominopelvic region and the lungs of children and young adults, although virtually any site in the body can be affected. 1, 2 Tumors involving the larynx are rare, as fewer than 40 cases have been reported in the English -language literature. 1, [3] [4] [5] [6] [7] To the best of our knowledge, we report the first published case of an IMT localized to the epiglottis.
Case report
A 66-year-old woman presented with complaints of dysphonia and odynophagia that had progressively worsened over several weeks. She denied any other complaints, and her medical history was noncontributory. Flexible fiberoptic laryngoscopy detected a small granular lesion with surrounding erythema involving the tip of the epiglottis (figure 1). Findings on the remainder of the examination were unremarkable. Computed tomography (CT) of the neck with contrast demonstrated a thickened suprahyoid epiglottis with nonpathologic lymphadenopathy of the anterior cervical chain bilaterally.
The patient underwent microdirect suspension laryngoscopy with a wide and complete excision of the epiglottic lesion with a CO 2 laser. No adjuvant therapy was used.
Macroscopic analysis of the mass demonstrated an excised 3.2 × 1.7 × 0.5-cm epiglottic specimen with a 1.2 × 0.7-cm depressed granular lesion that contained fragments of pink, red, and tan tissue on the mucosal surface. Biopsies of the mass identified an ulcerated mucosa with a subepithelial collection of epithelioid and spindled histiocytes admixed with lymphocytes and plasma cells ( figure 2) .
The patient experienced a resolution of her dysphonia as early as 4 weeks postoperatively, and she exhibited no evidence of recurrence after 6 months of follow-up (figure 3). The most common sites of laryngeal IMTs are the glottis (51% of cases), the subglottis (22.5%), and the anterior commissure (10%). 5 Reports of lesions involving the supraglottis are extremely rare; they include 1 case each originating in the aryepiglottic fold, vestibular fold, and vestibule. 5 To the best of our knowledge, ours is the first reported case of an IMT of the epiglottis.
Etiology. Laryngeal IMTs tend to affect adults (mean age: 44.5 yr), and the reported male-to-female ratio is 1.6:1. 5 The etiology of IMTs remains unclear, although some authors suspect that it involves an immunologic response to stimuli such as microorganisms, tissue damage, smoking, foreign bodies, or neoplasms.
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Clinical presentation. IMTs may present with nonspecific findings such as pain, fever, and weight loss; anemia and an elevated erythrocyte sedimentation rate may also manifest. 2 As occurred in our case, patients with laryngeal IMT have commonly presented with dysphonia (74%); less often they have presented with stridor (29%), dyspnea (22.5%), and globus (16%).
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Diagnosis. The diagnosis can be reached by a combination of investigations, including macroscopic and microscopic analysis, immunochemistry, and radiology.
Macroscopic analysis. In general, an IMT presents as a firm, fleshy, gelatinous lesion with a white or tan cut surface. A minority show calcification, necrosis and, as occurred in our case, hemorrhage.
1 Laryngeal IMTs in particular are often polypoid or pedunculated, but they also may present as a nodular elevation with inflamed, ulcerated, or hyperplastic mucosa. The size of laryngeal IMTs varies, ranging from 0.4 to 4.0 cm. [3] [4] [5] [6] [7] Microscopic analysis. Histologically, IMTs are composed of myofibroblasts mixed with an infiltrate of inflammatory cells (lymphocytes, plasma cells, eosinophils, and macrophages). Three basic histologic patterns described by Coffin et al are universally accepted:
• myxoid, vascular, and inflammatory areas resembling nodular fasciitis;
• compact spindle cells with intermingled inflammatory cells resembling fibrous histiocytoma; and
• dense plate-like collagen resembling a scar or desmoid-type fibromatosis. 1 Highly atypical cells are seen in rare IMTs that undergo histologic malignant transformation.
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Our patient's biopsies identified ulcerated mucosa with a subepithelial collection of epithelioid and spindled histiocytes admixed with lymphocytes and plasma cells. There was no atypia or necrosis. These findings are consistent with the second of the three types described by Coffin et al. 1 Immunohistochemistry. Immunohistochemical staining can aid in the diagnosis of laryngeal IMT. 
Figure 2. Histopathologic images of the resected tissue specimen. A: An accumulation of inflammatory cells consisting of histiocytes, lymphocytes, and plasma cells rest adjacent to the ulcerated mucosa (H and E, original magnification ×10). B: An admixture of cells contains epithelioid histiocytes, lymphocytes, and plasma cells (H and E, original magnification ×20).
A kappa (88.3/hpf)-to-lambda (88.1/ hpf) ratio of 1.1:1 supports the presence of a reactive plasma cell infiltrate consistent with plasma cell granuloma. Muscle-specific actin, vimentin, and smooth-muscle actin are often present, but their specificity is low. Desmin and cytokeratins can stain positive, as well. Radiology. Although the radiologic findings of epiglottic thickening in our case were rather nonspecific, preoperative imaging can assist in the diagnosis of laryngeal IMTs. Contrast-enhanced CT may demonstrate a well-enhanced mass. Magnetic resonance imaging will show a mixed high and low signal intensity on T2-weighted images and a well-enhanced lesion on gadolinium-enhanced T1-weighted images. 9 The differential diagnosis includes soft-tissue tumors such as angioleiomyoma, leiomyoblastoma, and leiomyosarcoma, as well as malignant tumors such as squamous cell carcinoma, lymphoma, malignant fibrous histiocytoma, and spindle-cell squamous carcinoma.
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Treatment. The mainstay of treatment for a laryngeal IMT is complete surgical excision (with or without laser ablation). Microsuspension direct laryngoscopy or direct laryngoscopy with endoscopy is preferred over an open procedure, which is reserved for cases of recurrence or poor visualization or when malignancy cannot be ruled out. 5 Steroids and nonsteroidal antiinflammatory drugs have been used both independently and as an adjuvant therapy, although isolated therapy with either seems to be less efficacious. The role of antibiotics is less certain.
Radiation and chemotherapy are used to treat recurrent IMTs, including lesions that have undergone malignant transformation. In some patients with multiple recurrences, a laryngectomy may be warranted. [1] [2] [3] [4] [5] 7 Regardless of the treatment used, a high recurrence rate (27.3%) for laryngeal IMTs warrants thorough postoperative follow-up. 5 No cases of laryngeal IMT metastasis have been reported to date. 4 Our patient underwent successful excision of an epiglottic IMT with a CO 2 laser, and she exhibited no evidence of recurrence after 6 months of follow-up.
Conclusion
Laryngeal IMTs are rare, and they pose a diagnostic challenge. Histologically, the appearance of an IMT may mimic that of a malignancy. The benign nature of this lesion precludes aggressive treatment, but their potential for local expansion warrants prompt intervention. Complete endoscopic surgical excision (with or without adjuvant therapy) is the preferred treatment for laryngeal IMTs. To the best of our knowledge, our case represents the first published report of a laryngeal IMT affecting the epiglottis. 
